Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility-Reference-Cited by-同舟云学术

Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility

Published:2023-08 Issue:8 Volume:41 Page:357.e11-357.e21
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Morgans Alicia K.,Galsky Matthew D.,Wright Phoebe,Hepp Zsolt,Chang Nancy,Willmon Candice L.,Sesterhenn Steve,Liu Yutong,Sonpavde Guru P.

Funder

Astellas Pharma US

Seagen

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference25 articles.

1. American Cancer Society. Survival rates for bladder cancer, www.cancer.org/cancer/bladder-cancer/detection-diagnosis-staging/survival-rates.html; [Accessed June 3, 2022].

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines®) for bladder cancer V.5.2021, https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf; 2021 [Accessed November 2, 2021].

3. Epidemiology of bladder cancer;Saginala;Med Sci (Basel),2020

4. Surveillance Epidemiology and End Results Program (NCI). Cancer stat facts: bladder cancer, https://seer.cancer.gov/statfacts/html/urinb.html; 2021 [Accessed June 3, 2022].

5. Clinical evidence for the first-line treatment of advanced urothelial carcinoma: current paradigms and emerging treatment options;Koufopoulou;Cancer Treat Rev,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding;The Patient - Patient-Centered Outcomes Research;2024-08-28

2. A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma;Targeted Oncology;2024-07

3. Editorial Comment on “Real‐world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey”;International Journal of Urology;2024-06-02

4. Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma;European Urology Focus;2024-06

5. Therapy Attrition and Lessons for Future Approaches to Treatment of Advanced Urothelial Cancer;JAMA Network Open;2024-05-02